16 studies found for:    " April 18, 2007":" May 18, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 18, 2007":" May 18, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
2 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
3 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
4 Completed Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
Condition: HIV Infections
Interventions: Biological: VRC-HIVADV027-00-VP;   Biological: VRC-HIVADV038-00-VP;   Biological: VRC-HIVDNA044-00-VP
5 Completed A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method
Condition: HIV Infections
Intervention: Device: intravaginal ring
6 Completed A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
Condition: HIV Infections
Interventions: Drug: dapivirine reservoir intravaginal ring;   Drug: dapivirine matrix intravaginal ring;   Other: placebo intravaginal ring
7 Completed Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Conditions: HIV Infections;   Insulin Resistance;   Hyperlactatemia
Intervention: Drug: NucleomaxX (contains uridine)
8 Unknown  Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Emtricitabine/tenofovir/efavirenz
9 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
10 Completed
Has Results
The Treatment of Insomnia in Patients With HIV Disease
Conditions: HIV Infections;   Insomnia
Interventions: Drug: Doxepin;   Drug: Temazepam;   Drug: Placebo
11 Completed Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")
Condition: HIV Infections
Intervention: Behavioral: standard versus enhanced risk reduction counseling
12 Completed HIV and Cardiovascular Risk
Conditions: HIV Infections;   Cardiovascular Disease
Intervention:
13 Completed Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: Peginterferón alfa-2a (40 KD) (Pegasys®) 180 ug/week;   Drug: Ribavirin (Copegus®) 1600 mg/day;   Drug: Epoetin β (450 UI/kg/week)
14 Completed Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Behavioral: Nevirapine from twice-a-day to once-a-day
15 Completed
Has Results
Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
Condition: Healthy Volunteers
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Gemfibrozil
16 Completed 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides
Condition: Sexually Transmitted Infections
Interventions: Other: 62% ethanol in emollient gel;   Drug: Placebo;   Other: 15% ethanol in emollient gel

Indicates status has not been verified in more than two years